For information about enrolling in our Phase 2, randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of Leronlimab in patients experiencing Long-Haulers, please contact: 

Arthritis & Rheumatic Disease Specialties
Site Contact:
Joanne Sagliani: (305) 932-4162

Principal Investigator
Norman B. Gaylis, M.D.
Main telephone: (305) 652-6676
2801 NE 213th St.
Suite 801
Aventura, FL 33180

Center for Advanced Research & Education (CARE)
Site Contact:
Tina Foreman: (678) 928-6476

Principal Investigator
Angela Ritter, M.D. 
Main telephone: (770) 534-5154
2350 Limestone Parkway
Gainesville, GA 30501